<i>GFAP</i> mutations, age at onset, and clinical subtypes in Alexander disease

Abstract

AAO and the GFAP mutation site are important clinical predictors in AxD, with clear correlations to defined patterns of phenotypic expression. We propose revised AxD subtypes, type I and type II, based on analysis of statistically defined patient groups.